Esoteric Testing Market: By Type (Infectious Diseases Testing, Endocrinology Testing, Oncology Testing, Genetics Testing, Toxicology Testing, Immunology Testing, Neurology Testing, Other Testing), By Technology (Chemiluminescence Immunoassay, Enzyme-Linked Immunosorbent Assay, Mass Spectrometry, Real-Time PCR, DNA Sequencing, Flow Cytometry, Other Technologies), By End User (Independent & Reference Laboratories, Hospital-Based Laboratories), And Region – Global Analysis of Market Size, Share & Trends For 2019–2021 And Forecasts To 2031
Esoteric Testing Market: By Type (Infectious Diseases Testing, Endocrinology Testing, Oncology Testing, Genetics Testing, Toxicology Testing, Immunology Testing, Neurology Testing, Other Testing), By Technology (Chemiluminescence Immunoassay, Enzyme-Linked Immunosorbent Assay, Mass Spectrometry, Real-Time PCR, DNA Sequencing, Flow Cytometry, Other Technologies), By End User (Independent & Reference Laboratories, Hospital-Based Laboratories), And Region – Global Analysis of Market Size, Share & Trends For 2019–2021 And Forecasts To 2031
PRODUCT OVERVIEW
Esoteric testing is a laboratory analysis of a rare chemical or substance that isn't done in a typical clinical lab. When a physician requires further and specific information regarding a patient's health, these tests are conducted. To assess the results, you'll need a sophisticated device and materials, as well as a competent technician. Reference and esoteric testing labs are used by many large commercial labs to outsource difficult tests. However, as laboratory testing technology advances, tests that are currently deemed exotic may become routine in just a few years.
MARKET HIGHLIGHTS
The Global Esoteric Testing Market is expected to achieve a remarkable CAGR of 13% in 2031.
Global Esoteric Testing Market to surpass USD 88.4 billion by 2031 from USD 26.2 billion in 2021 at a CAGR of 13% in the coming years, i.e., 2021-2031. Increased frequency of chronic, infectious, and rare genetic diseases, as well as increased demand for enzyme linked immunosorbent assay (ELISA) and real time polymerase chain reaction (RT-PCR), are propelling the market forward. Furthermore, the market is likely to benefit from increased financing from commercial and government entities for diagnostic service centres, as well as advancements in technology for esoteric testing.
GLOBAL ESOTERIC TESTING MARKET: SEGMENTS
Infectious Diseases Testing segment is expected to lead with the highest CAGR during 2021-31
Based on Type, the global Esoteric Testing Market is fragmented into Infectious Diseases Testing, Endocrinology Testing, Oncology Testing, Genetics Testing, Toxicology Testing, Immunology Testing, Neurology Testing, and Other Testing. The infectious disease testing segment has dominated the market in recent years and is likely to continue to do so in the future, owing to an increase in the frequency of infection disease, breakthroughs in healthcare laboratory technology, and advances in molecular diagnostic technology.
Independent & Reference Laboratories segment to register significant market share CAGR during 2021-31
Global Esoteric Testing Market is classified on the basis of End User into Independent & Reference Laboratories, and Hospital-Based Laboratories. Owing to an increase in the number of laboratories, high testing volumes, and a spike in diagnostic laboratory digitalization, the independent and reference laboratories segment led the market in past years and is likely to continue this trend during the projection period.
MARKET DYNAMICS
Drivers
Growing Incidence of Chronic and Infectious Diseases
Improvements in Esoteric Test Technology
Restraint
Poor reimbursement of Esoteric Testing
GLOBAL ESOTERIC TESTING MARKET:
Key Players
Esoteric Testing Market Segments:
PRODUCT OVERVIEW
Esoteric testing is a laboratory analysis of a rare chemical or substance that isn't done in a typical clinical lab. When a physician requires further and specific information regarding a patient's health, these tests are conducted. To assess the results, you'll need a sophisticated device and materials, as well as a competent technician. Reference and esoteric testing labs are used by many large commercial labs to outsource difficult tests. However, as laboratory testing technology advances, tests that are currently deemed exotic may become routine in just a few years.
MARKET HIGHLIGHTS
The Global Esoteric Testing Market is expected to achieve a remarkable CAGR of 13% in 2031.
Global Esoteric Testing Market to surpass USD 88.4 billion by 2031 from USD 26.2 billion in 2021 at a CAGR of 13% in the coming years, i.e., 2021-2031. Increased frequency of chronic, infectious, and rare genetic diseases, as well as increased demand for enzyme linked immunosorbent assay (ELISA) and real time polymerase chain reaction (RT-PCR), are propelling the market forward. Furthermore, the market is likely to benefit from increased financing from commercial and government entities for diagnostic service centres, as well as advancements in technology for esoteric testing.
GLOBAL ESOTERIC TESTING MARKET: SEGMENTS
Infectious Diseases Testing segment is expected to lead with the highest CAGR during 2021-31
Based on Type, the global Esoteric Testing Market is fragmented into Infectious Diseases Testing, Endocrinology Testing, Oncology Testing, Genetics Testing, Toxicology Testing, Immunology Testing, Neurology Testing, and Other Testing. The infectious disease testing segment has dominated the market in recent years and is likely to continue to do so in the future, owing to an increase in the frequency of infection disease, breakthroughs in healthcare laboratory technology, and advances in molecular diagnostic technology.
Independent & Reference Laboratories segment to register significant market share CAGR during 2021-31
Global Esoteric Testing Market is classified on the basis of End User into Independent & Reference Laboratories, and Hospital-Based Laboratories. Owing to an increase in the number of laboratories, high testing volumes, and a spike in diagnostic laboratory digitalization, the independent and reference laboratories segment led the market in past years and is likely to continue this trend during the projection period.
MARKET DYNAMICS
Drivers
Growing Incidence of Chronic and Infectious Diseases
Improvements in Esoteric Test Technology
Restraint
Poor reimbursement of Esoteric Testing
GLOBAL ESOTERIC TESTING MARKET:
Key Players
- ARUP Laboratories
- Baylor Esoteric and Molecular Laboratory
- Foundation Medicine
- Healius Limited
- Laboratory Corporation
- Mayo Foundation for Medical Education and Research
- OPKO Health
- Quest Diagnostics
- Sonic Healthcare Limited
- Stanford Clinical Pathology
- Other Prominent Players
Esoteric Testing Market Segments:
- By Type
- Infectious Diseases Testing
- Endocrinology Testing
- Oncology Testing
- Genetics Testing
- Toxicology Testing
- Immunology Testing
- Neurology Testing
- Other Testing
- By Technology
- Chemiluminescence Immunoassay
- Enzyme-Linked Immunosorbent Assay
- Mass Spectrometry
- Real-Time PCR
- DNA Sequencing
- Flow Cytometry
- Other Technologies
- By End User
- Independent & Reference Laboratories
- Hospital-Based Laboratories
- Esoteric Testing Market Dynamics
- Esoteric Testing Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies Involved in the Market
- Value Chain of the Market
- Market Drivers and Restraints
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 3-month post-sales analyst support.
Executive Summary
1.1. Regional Market Share
1.2. Business Trends
1.3. Esoteric Testing Market: COVID-19 Outbreak
1.4. Regional Trends
1.5. Segmentation Snapshot
2 RESEARCH METHODOLOGY
2.1. Research Objective
2.2. Research Approach
2.3. Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1. Paid Sources
2.5.2. Public Sources
2.6. Market Size Estimation and Data Triangulation
3 MARKET CHARACTERISTICS
3.1. Market Definition
3.2. Esoteric Testing Market: COVID-19 Impact
3.3. Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4 ESOTERIC TESTING MARKET – INDUSTRY INSIGHTS
4.1. Industry Segmentation
4.2. COVID-19 overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability
5 MACROECONOMIC INDICATORS
6 RECENT DEVELOPMENTS
7 MARKET DYNAMICS
7.1. Introduction
7.2. Growth Drivers
7.3. Market Opportunities
7.4. Market Restraints
7.5. Market Trends
8 RISK ANALYSIS
9 MARKET ANALYSIS
9.1. Porters Five Forces
9.2. PEST Analysis
9.2.1. Political
9.2.2. Economic
9.2.3. Social
9.2.4. Technological
10 ESOTERIC TESTING MARKET
10.1. Overview
10.2. Historical Analysis (2016-2020)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11 ESOTERIC TESTING MARKET SIZE & FORECAST 2021A-2031F
11.1. Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1. By Type
11.3.1.1. Infectious Diseases Testing
11.3.1.1.1. By Value (USD Million) 2021-2031F
11.3.1.1.2. Market Share (%) 2021-2031F
11.3.1.1.3. Y-o-Y Growth (%) 2021-2031F
11.3.1.2. Endocrinology Testing
11.3.1.2.1. By Value (USD Million) 2021-2031F
11.3.1.2.2. Market Share (%) 2021-2031F
11.3.1.2.3. Y-o-Y Growth (%) 2021-2031F
11.3.1.3. Oncology Testing
11.3.1.3.1. By Value (USD Million) 2021-2031F
11.3.1.3.2. Market Share (%) 2021-2031F
11.3.1.3.3. Y-o-Y Growth (%) 2021-2031F
11.3.1.4. Genetics Testing
11.3.1.4.1. By Value (USD Million) 2021-2031F
11.3.1.4.2. Market Share (%) 2021-2031F
11.3.1.4.3. Y-o-Y Growth (%) 2021-2031F
11.3.1.5. Toxicology Testing
11.3.1.5.1. By Value (USD Million) 2021-2031F
11.3.1.5.2. Market Share (%) 2021-2031F
11.3.1.5.3. Y-o-Y Growth (%) 2021-2031F
11.3.1.6. Immunology Testing
11.3.1.6.1. By Value (USD Million) 2021-2031F
11.3.1.6.2. Market Share (%) 2021-2031F
11.3.1.6.3. Y-o-Y Growth (%) 2021-2031F
11.3.1.7. Neurology Testing
11.3.1.7.1. By Value (USD Million) 2021-2031F
11.3.1.7.2. Market Share (%) 2021-2031F
11.3.1.7.3. Y-o-Y Growth (%) 2021-2031F
11.3.1.8. Other Testing
11.3.1.8.1. By Value (USD Million) 2021-2031F
11.3.1.8.2. Market Share (%) 2021-2031F
11.3.1.8.3. Y-o-Y Growth (%) 2021-2031F
11.3.2. By Technology
11.3.2.1. Chemiluminescence Immunoassay
11.3.2.1.1. By Value (USD Million) 2021-2031F
11.3.2.1.2. Market Share (%) 2021-2031F
11.3.2.1.3. Y-o-Y Growth (%) 2021-2031F
11.3.2.2. Enzyme-Linked Immunosorbent Assay
11.3.2.2.1. By Value (USD Million) 2021-2031F
11.3.2.2.2. Market Share (%) 2021-2031F
11.3.2.2.3. Y-o-Y Growth (%) 2021-2031F
11.3.2.3. Mass Spectrometry
11.3.2.3.1. By Value (USD Million) 2021-2031F
11.3.2.3.2. Market Share (%) 2021-2031F
11.3.2.3.3. Y-o-Y Growth (%) 2021-2031F
11.3.2.4. Real-Time PCR
11.3.2.4.1. By Value (USD Million) 2021-2031F
11.3.2.4.2. Market Share (%) 2021-2031F
11.3.2.4.3. Y-o-Y Growth (%) 2021-2031F
11.3.2.5. DNA Sequencing
11.3.2.5.1. By Value (USD Million) 2021-2031F
11.3.2.5.2. Market Share (%) 2021-2031F
11.3.2.5.3. Y-o-Y Growth (%) 2021-2031F
11.3.2.6. Flow Cytometry
11.3.2.6.1. By Value (USD Million) 2021-2031F
11.3.2.6.2. Market Share (%) 2021-2031F
11.3.2.6.3. Y-o-Y Growth (%) 2021-2031F
11.3.2.7. Other Technologies
11.3.2.7.1. By Value (USD Million) 2021-2031F
11.3.2.7.2. Market Share (%) 2021-2031F
11.3.2.7.3. Y-o-Y Growth (%) 2021-2031F
11.3.3. By End User
11.3.3.1. Independent & Reference Laboratories
11.3.3.1.1. By Value (USD Million) 2021-2031F
11.3.3.1.2. Market Share (%) 2021-2031F
11.3.3.1.3. Y-o-Y Growth (%) 2021-2031F
11.3.3.2. Hospital-Based Laboratories
11.3.3.2.1. By Value (USD Million) 2021-2031F
11.3.3.2.2. Market Share (%) 2021-2031F
11.3.3.2.3. Y-o-Y Growth (%) 2021-2031F
12 NORTH AMERICA ESOTERIC TESTING MARKET SIZE & FORECAST 2021A-2031F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Type
12.3.2. By Technology
12.3.3. By End User
12.3.4. Country
12.3.5. United States
12.3.6. Canada
13 EUROPE ESOTERIC TESTING MARKET SIZE & FORECAST 2021A-2031F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Type
13.3.2. By Technology
13.3.3. By End User
13.4. Country
13.4.1. Germany
13.4.2. United Kingdom
13.4.3. France
13.4.4. Italy
13.4.5. Spain
13.4.6. Russia
13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14 ASIA ESOTERIC TESTING MARKET SIZE & FORECAST 2021A-2031F
14.1. Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Type
14.3.2. By Technology
14.3.3. By End User
14.4. By Country
14.4.1. India
14.4.2. China
14.4.3. South Korea
14.4.4. Japan
14.4.5. Rest of APAC
15 MIDDLE EAST AND AFRICA ESOTERIC TESTING MARKET SIZE & FORECAST 2021A-2031F
15.1. Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Type
15.3.2. By Technology
15.3.3. By End User
15.4. Country
15.4.1. Israel
15.4.2. GCC
15.4.3. North Africa
15.4.4. South Africa
15.4.5. Rest of Middle East and Africa
16 LATIN AMERICA ESOTERIC TESTING MARKET SIZE & FORECAST 2021A-2031F
16.1. Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1. By Type
16.3.2. By Technology
16.3.3. By End User
16.4. Country
16.4.1. Mexico
16.4.2. Brazil
16.4.3. Rest of Latin America
17 COMPETITIVE LANDSCAPE
17.1. Company market share, 2021
17.2. Key player overview
17.3. Key stakeholders
18 COMPANY PROFILES
18.1. ARUP Laboratories
18.1.1. Company Overview
18.1.2. Financial Overview
18.1.3. Key Product; Analysis
18.1.4. Company Assessment
18.1.4.1. Product Portfolio
18.1.4.2. Key Clients
18.1.4.3. Market Share
18.1.4.4. Recent News & Development (Last 3 Yrs.)
18.1.4.5. Executive Team
18.2. Baylor Esoteric and Molecular Laboratory
18.3. Foundation Medicine
18.4. Healius Limited
18.5. Laboratory Corporation
18.6. Mayo Foundation for Medical Education and Research
18.7. OPKO Health
18.8. Quest Diagnostics
18.9. Sonic Healthcare Limited
18.10. Stanford Clinical Pathology
18.11. Other Prominent Players
19 APPENDIX
20 CONSULTANT RECOMMENDATION
1.1. Regional Market Share
1.2. Business Trends
1.3. Esoteric Testing Market: COVID-19 Outbreak
1.4. Regional Trends
1.5. Segmentation Snapshot
2 RESEARCH METHODOLOGY
2.1. Research Objective
2.2. Research Approach
2.3. Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1. Paid Sources
2.5.2. Public Sources
2.6. Market Size Estimation and Data Triangulation
3 MARKET CHARACTERISTICS
3.1. Market Definition
3.2. Esoteric Testing Market: COVID-19 Impact
3.3. Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4 ESOTERIC TESTING MARKET – INDUSTRY INSIGHTS
4.1. Industry Segmentation
4.2. COVID-19 overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability
5 MACROECONOMIC INDICATORS
6 RECENT DEVELOPMENTS
7 MARKET DYNAMICS
7.1. Introduction
7.2. Growth Drivers
7.3. Market Opportunities
7.4. Market Restraints
7.5. Market Trends
8 RISK ANALYSIS
9 MARKET ANALYSIS
9.1. Porters Five Forces
9.2. PEST Analysis
9.2.1. Political
9.2.2. Economic
9.2.3. Social
9.2.4. Technological
10 ESOTERIC TESTING MARKET
10.1. Overview
10.2. Historical Analysis (2016-2020)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11 ESOTERIC TESTING MARKET SIZE & FORECAST 2021A-2031F
11.1. Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1. By Type
11.3.1.1. Infectious Diseases Testing
11.3.1.1.1. By Value (USD Million) 2021-2031F
11.3.1.1.2. Market Share (%) 2021-2031F
11.3.1.1.3. Y-o-Y Growth (%) 2021-2031F
11.3.1.2. Endocrinology Testing
11.3.1.2.1. By Value (USD Million) 2021-2031F
11.3.1.2.2. Market Share (%) 2021-2031F
11.3.1.2.3. Y-o-Y Growth (%) 2021-2031F
11.3.1.3. Oncology Testing
11.3.1.3.1. By Value (USD Million) 2021-2031F
11.3.1.3.2. Market Share (%) 2021-2031F
11.3.1.3.3. Y-o-Y Growth (%) 2021-2031F
11.3.1.4. Genetics Testing
11.3.1.4.1. By Value (USD Million) 2021-2031F
11.3.1.4.2. Market Share (%) 2021-2031F
11.3.1.4.3. Y-o-Y Growth (%) 2021-2031F
11.3.1.5. Toxicology Testing
11.3.1.5.1. By Value (USD Million) 2021-2031F
11.3.1.5.2. Market Share (%) 2021-2031F
11.3.1.5.3. Y-o-Y Growth (%) 2021-2031F
11.3.1.6. Immunology Testing
11.3.1.6.1. By Value (USD Million) 2021-2031F
11.3.1.6.2. Market Share (%) 2021-2031F
11.3.1.6.3. Y-o-Y Growth (%) 2021-2031F
11.3.1.7. Neurology Testing
11.3.1.7.1. By Value (USD Million) 2021-2031F
11.3.1.7.2. Market Share (%) 2021-2031F
11.3.1.7.3. Y-o-Y Growth (%) 2021-2031F
11.3.1.8. Other Testing
11.3.1.8.1. By Value (USD Million) 2021-2031F
11.3.1.8.2. Market Share (%) 2021-2031F
11.3.1.8.3. Y-o-Y Growth (%) 2021-2031F
11.3.2. By Technology
11.3.2.1. Chemiluminescence Immunoassay
11.3.2.1.1. By Value (USD Million) 2021-2031F
11.3.2.1.2. Market Share (%) 2021-2031F
11.3.2.1.3. Y-o-Y Growth (%) 2021-2031F
11.3.2.2. Enzyme-Linked Immunosorbent Assay
11.3.2.2.1. By Value (USD Million) 2021-2031F
11.3.2.2.2. Market Share (%) 2021-2031F
11.3.2.2.3. Y-o-Y Growth (%) 2021-2031F
11.3.2.3. Mass Spectrometry
11.3.2.3.1. By Value (USD Million) 2021-2031F
11.3.2.3.2. Market Share (%) 2021-2031F
11.3.2.3.3. Y-o-Y Growth (%) 2021-2031F
11.3.2.4. Real-Time PCR
11.3.2.4.1. By Value (USD Million) 2021-2031F
11.3.2.4.2. Market Share (%) 2021-2031F
11.3.2.4.3. Y-o-Y Growth (%) 2021-2031F
11.3.2.5. DNA Sequencing
11.3.2.5.1. By Value (USD Million) 2021-2031F
11.3.2.5.2. Market Share (%) 2021-2031F
11.3.2.5.3. Y-o-Y Growth (%) 2021-2031F
11.3.2.6. Flow Cytometry
11.3.2.6.1. By Value (USD Million) 2021-2031F
11.3.2.6.2. Market Share (%) 2021-2031F
11.3.2.6.3. Y-o-Y Growth (%) 2021-2031F
11.3.2.7. Other Technologies
11.3.2.7.1. By Value (USD Million) 2021-2031F
11.3.2.7.2. Market Share (%) 2021-2031F
11.3.2.7.3. Y-o-Y Growth (%) 2021-2031F
11.3.3. By End User
11.3.3.1. Independent & Reference Laboratories
11.3.3.1.1. By Value (USD Million) 2021-2031F
11.3.3.1.2. Market Share (%) 2021-2031F
11.3.3.1.3. Y-o-Y Growth (%) 2021-2031F
11.3.3.2. Hospital-Based Laboratories
11.3.3.2.1. By Value (USD Million) 2021-2031F
11.3.3.2.2. Market Share (%) 2021-2031F
11.3.3.2.3. Y-o-Y Growth (%) 2021-2031F
12 NORTH AMERICA ESOTERIC TESTING MARKET SIZE & FORECAST 2021A-2031F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Type
12.3.2. By Technology
12.3.3. By End User
12.3.4. Country
12.3.5. United States
12.3.6. Canada
13 EUROPE ESOTERIC TESTING MARKET SIZE & FORECAST 2021A-2031F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Type
13.3.2. By Technology
13.3.3. By End User
13.4. Country
13.4.1. Germany
13.4.2. United Kingdom
13.4.3. France
13.4.4. Italy
13.4.5. Spain
13.4.6. Russia
13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14 ASIA ESOTERIC TESTING MARKET SIZE & FORECAST 2021A-2031F
14.1. Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Type
14.3.2. By Technology
14.3.3. By End User
14.4. By Country
14.4.1. India
14.4.2. China
14.4.3. South Korea
14.4.4. Japan
14.4.5. Rest of APAC
15 MIDDLE EAST AND AFRICA ESOTERIC TESTING MARKET SIZE & FORECAST 2021A-2031F
15.1. Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Type
15.3.2. By Technology
15.3.3. By End User
15.4. Country
15.4.1. Israel
15.4.2. GCC
15.4.3. North Africa
15.4.4. South Africa
15.4.5. Rest of Middle East and Africa
16 LATIN AMERICA ESOTERIC TESTING MARKET SIZE & FORECAST 2021A-2031F
16.1. Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1. By Type
16.3.2. By Technology
16.3.3. By End User
16.4. Country
16.4.1. Mexico
16.4.2. Brazil
16.4.3. Rest of Latin America
17 COMPETITIVE LANDSCAPE
17.1. Company market share, 2021
17.2. Key player overview
17.3. Key stakeholders
18 COMPANY PROFILES
18.1. ARUP Laboratories
18.1.1. Company Overview
18.1.2. Financial Overview
18.1.3. Key Product; Analysis
18.1.4. Company Assessment
18.1.4.1. Product Portfolio
18.1.4.2. Key Clients
18.1.4.3. Market Share
18.1.4.4. Recent News & Development (Last 3 Yrs.)
18.1.4.5. Executive Team
18.2. Baylor Esoteric and Molecular Laboratory
18.3. Foundation Medicine
18.4. Healius Limited
18.5. Laboratory Corporation
18.6. Mayo Foundation for Medical Education and Research
18.7. OPKO Health
18.8. Quest Diagnostics
18.9. Sonic Healthcare Limited
18.10. Stanford Clinical Pathology
18.11. Other Prominent Players
19 APPENDIX
20 CONSULTANT RECOMMENDATION
